Data / Form D filings / Zosano Pharma Corp
Zosano Pharma Corp: Form D filings
Zosano Pharma Corp, a pharmaceuticals company in Fremont, CA, filed 6 Form D notices with the SEC between 2013 and 2016. The latest, on August 29, 2016, reports $7.5 million sold of a $7.5 million offering to 18 investors.
Find out what Zosano Pharma Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 34790 ARDENTECH COURT, Fremont, CA, 94555
- Phone
- (510) 745-1200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1587221
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 29, 2016 | New notice | $7,536,000 | $7,536,000 | $0 | 18 | Aug 19, 2016 | sec.gov |
| Jun 30, 2015 | New notice | $300,000 | $0 | $300,000 | 1 | Jun 23, 2015 | sec.gov |
| Feb 3, 2015 | New notice | $15,000,000 | $14,999,996 | $4 | 1 | Jan 30, 2015 | sec.gov |
| Dec 4, 2014 | New notice | $2,000,000 | $1,333,000 | $667,000 | 2 | Dec 2, 2014 | sec.gov |
| Mar 5, 2014 | New notice | $2,500,000 | $2,500,000 | $0 | 3 | Feb 26, 2014 | sec.gov |
| Sep 20, 2013 | New notice | $3,033,723 | $3,033,723 | $0 | 5 | Sep 9, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bruce D. Steel | Director | |
| Kleanthis D. Xanthopoulos | Director | |
| John Walker | Director | |
| Haley D. Lewis | Executive Officer | |
| Troy D. Wilson | Director | |
| Donald D. Kellerman | Executive Officer | |
| Joseph P. Hagan | Director | |
| Winnie D. Tso | Executive Officer | |
| Konstantinos Alataris | Executive Officer, Director | |
| Eric D. Scharin | Executive Officer | |
| Georgia D. Erbez | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Aug 29, 2016 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Zosano Pharma Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.